H.R. 4299

119th CongressIn committee

Protecting Patient Access to Cancer and Complex Therapies Act

Protecting Patient Access to Cancer and Complex Therapies Act

Sponsored by Gregory F. Murphy (Republican-NC-3)

Healthcare Costs & Access Healthcare & Public Health Pharmaceutical Policy

Cosponsors

36

Actions

3

Roll calls

0

Amendments

0

Related bills

1

Actions

Jul 7, 2025 · Library of Congress

Introduced in House

Jul 7, 2025 · Library of Congress

Introduced in House

Jul 7, 2025 · House floor actions

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Latest activity

Activity

July 2026

Lobbying reported · Todd Strategy Group · Jul 21

Todd Strategy Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Takeda Pharmaceuticals America — $50,000

Lobbying reported · Bristol Myers Squibb · Jul 20

Bristol Myers Squibb reported 2nd Quarter (Apr 1 - June 30) lobbying for Bristol Myers Squibb — $3,160,000

BillsH.R. 1492 H.R. 4299 H.R. 5509 H.R. 7391 H.R. 7635

Lobbying reported · American College of Rheumatology · Jul 20

American College of Rheumatology reported 2nd Quarter (Apr 1 - June 30) lobbying for American College of Rheumatology — $180,000

Lobbying reported · AbbVie · Jul 20

AbbVie reported 2nd Quarter (Apr 1 - June 30) lobbying for AbbVie — $1,160,000

BillsH.R. 1 H.R. 1328 H.R. 4299 H.R. 5376 H.R. 5509 S. 864 S. 1040 S. 2903

Lobbying reported · Amgen · Jul 20

Amgen reported 2nd Quarter (Apr 1 - June 30) lobbying for Amgen — $2,440,000

Lobbying reported · Johnson & Johnson Services · Jul 20

Johnson & Johnson Services reported 2nd Quarter (Apr 1 - June 30) lobbying for Johnson & Johnson Services — $1,440,000

Lobbying reported · Cencora Inc. (formerly Amerisourcebergen Corporation) · Jul 20

Cencora Inc. (formerly Amerisourcebergen Corporation) reported 2nd Quarter (Apr 1 - June 30) lobbying for Cencora Inc. (formerly Amerisourcebergen Corporation) — $510,000

BillsH.R. 363 H.R. 2213 H.R. 3164 H.R. 4299 H.R. 8800 S. 2426 S. 3822

Lobbying reported · Mckesson Corporation & Affiliates U.S. Oncology And Rx Savings Solutions (formerly Mckesson Corp) · Jul 20

Mckesson Corporation & Affiliates U.S. Oncology And Rx Savings Solutions (formerly Mckesson Corp) reported 2nd Quarter (Apr 1 - June 30) lobbying for Mckesson Corporation & Affiliates U.S. Oncology And Rx Savings Solutions (formerly Mckesson Corp) — $530,000

BillsH.R. 1 H.R. 2120 H.R. 2444 H.R. 2484 H.R. 3164 H.R. 3514 H.R. 3521 H.R. 4299 S. 257 S. 1816 S. 3822

Lobbying reported · Stanton Park Group · Jul 20

Stanton Park Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Mckesson Corpation And Its Affiliate US Oncology (formerly US Oncology) — $60,000

BillsH.R. 2484 H.R. 4299

Lobbying reported · Avenue Solutions · Jul 20

Avenue Solutions reported 2nd Quarter (Apr 1 - June 30) lobbying for Merck & — $50,000

Lobbying reported · Avenue Solutions · Jul 20

Avenue Solutions reported 2nd Quarter (Apr 1 - June 30) lobbying for Large Urology Group Practice Association (lugpa) — $60,000

BillsH.R. 2484 H.R. 4299 H.R. 5582 H.R. 9393 H.R. 9504 S. 2355

Lobbying reported · Avenue Solutions · Jul 20

Avenue Solutions reported 2nd Quarter (Apr 1 - June 30) lobbying for Genentech USA — $50,000

BillsH.R. 1492 H.R. 1672 H.R. 4299

Lobbying reported · Avenue Solutions · Jul 20

Avenue Solutions reported 2nd Quarter (Apr 1 - June 30) lobbying for Bristol Myers Squibb — $60,000

Lobbying reported · Avenue Solutions · Jul 20

Avenue Solutions reported 2nd Quarter (Apr 1 - June 30) lobbying for Amgen — $50,000

BillsH.R. 4299 H.R. 5526 S. 1954

Lobbying reported · Pfizer · Jul 20

Pfizer reported 2nd Quarter (Apr 1 - June 30) lobbying for Pfizer — $1,880,000

BillsH.Con.Res. 14 H.R. 1 H.R. 4299 H.R. 4930 H.R. 5178 H.R. 5526 H.R. 7391 H.R. 7837 H.R. 8646 H.R. 9102 H.R. 9260 S. 2658

Lobbying reported · The Mcmanus Group · Jul 20

The Mcmanus Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Research and Manufacturers of America (PhRMA) — $60,000

BillsH.R. 1492 H.R. 4299 H.R. 9504 S. 832

Lobbying reported · The Mcmanus Group · Jul 20

The Mcmanus Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Large Urology Group Practice Association (lugpa) — $90,000

BillsH.R. 2474 H.R. 2484 H.R. 4299 H.R. 8163 H.R. 9504

Lobbying reported · The Mcmanus Group · Jul 20

The Mcmanus Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Infusion Providers Alliance — $90,000

Lobbying reported · The Mcmanus Group · Jul 20

The Mcmanus Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Gilead Sciences — $60,000

BillsH.R. 1492 H.R. 4299

Lobbying reported · The Mcmanus Group · Jul 20

The Mcmanus Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Genentech — $50,000

BillsH.R. 4299 H.R. 9504